MPM BioImpact

Boston, United States

MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.

$20.0M raised

Jan 2025

Corporate Round

Angel Investment Biotechnology Financial Services

Top Investors

Meiji Seika Pharma

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MPM BioImpact

How much funding has MPM BioImpact raised?

MPM BioImpact has raised $20.0M in total funding. The most recent round was Corporate Round. The last funding was announced in January 2025.

Who are MPM BioImpact's investors?

MPM BioImpact's investors include Meiji Seika Pharma.

Where is MPM BioImpact headquartered?

MPM BioImpact is headquartered in Boston, United States.

What does MPM BioImpact do?

MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.

What stage is MPM BioImpact at?

MPM BioImpact is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 10, 2025.

MLA

"MPM BioImpact — Funding & Investors." VCBacked, January 10, 2025, https://www.vcbacked.co/company/mpm-bioimpact. Accessed July 2, 2026.

APA

VCBacked. (2025). MPM BioImpact — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mpm-bioimpact

Wikipedia (cite web)

{{cite web |title=MPM BioImpact — Funding & Investors |url=https://www.vcbacked.co/company/mpm-bioimpact |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 10, 2025.

Similar Companies in Angel Investment